Robert brings to Norwest more than a decade of operational and medical experience. At NVP he focuses on investing capital in venture and growth opportunities in the healthcare sector, including digital health and healthcare IT, technology enabled healthcare services, medical devices, diagnostics, and specialty pharma. He currently serves on the board of iCardiac, is a board observer at Crossover Health, IntersectENT (NASDAQ: XENT), iRhythm, and Telcare, and was involved with the initial investments in Misfit Wearables and Health Catalyst. He has also been involved in follow-on investments in Simpirica Spine and BASIS. Prior to NVP, Robert was the Vice President of Marketing and Business Development at Hansen Medical Inc. (Nasdaq: HNSN). Previous to Hansen Medical, Robert worked in the device, pharmaceutical and biotech industries with experience at a number of companies, working in strategic, business development and marketing capacities. Robert is also a board certified emergency physician who completed his residency training at Stanford. He received his M.D. from Harvard Medical School and his M.B.A. from Harvard Business School. Robert received his B.S. in biomedical engineering from Johns Hopkins University. He has completed fellowships under the Howard Hughes Medical Institute (neuroscience), MIT Sloan School of Management, and Harvard Business School.
Keynote: Robert Mittendorff, Norwest Venture Partners